Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05364450 · ClinicalTrials.gov registry record · NA
Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 390
- Enrollment target
NCT05364450 is a NA study that has completed, run by Indiana University. The registered enrollment target is 390 participants.
The verdict
NCT05364450, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 390 participants
- Enrollment target
Study Summary
Fear of cancer recurrence (FCR) is a highly prevalent, disruptive, and under-treated problem for breast cancer survivors. This randomized controlled trial will test the efficacy of group-based Acceptance and Commitment Therapy compared to Cognitive Behavioral Therapy and enhanced usual care for breast cancer survivors suffering from FCR while examining its cost-effectiveness and the mechanisms by which the intervention may work. Study findings will guide the future care of breast cancer survivors with FCR.
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Acceptance Commitment Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2021-08-17 |
| Est. Completion | 2024-07-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05364450
The ClinicalTrials.gov registry entry for NCT05364450 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Enhanced Usual Care is the first listed.
NCT05364450 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05364450 about?
NCT05364450 is a clinical study titled "Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors". Fear of cancer recurrence (FCR) is a highly prevalent, disruptive, and under-treated problem for breast cancer survivors. This randomized controlled trial will test the efficacy of group-based Acceptance and Commitment Therapy compared to Cognitive Behavioral Therapy and enhanced usual care for brea...
What is the current status of trial NCT05364450?
This trial is currently completed. It is a NA study. The enrollment target is 390 participants. The study started on 2021-08-17. Estimated completion is 2024-07-09.
What interventions are being tested in trial NCT05364450?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Cognitive Behavioral Therapy (BEHAVIORAL), Acceptance Commitment Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05364450?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.